Consumer safety guide for blood thinner available
Accreditation Connection, May 30, 2008
The Agency for Healthcare Research and Quality has issued a consumer safety guide intended to help patients with the use of warfarin (also commonly known as Coumadin).
The guide provides information of possible side effects that could cause patient harm, as well as important dosing information.
The guide can be found online here.
Comments
0 comments on “Consumer safety guide for blood thinner available ”
Related Products
-
Briefings on The Joint Commission
Briefings on The Joint Commission will help you with all of your accreditation and survey preparation needs. Every month...
-
The Joint Commission Mock Tracer Made Simple
This updated edition of our annual best-seller includes new tools and case studies of successful tracers from facilities...
-
Staffing Effectiveness Data:
You've spent an enormous amount of time, money, and effort collecting staffing effectiveness data - and you can still put it...
-
Simplifying Nursing Documentation
Implement a "two-form" solution that will cut nursing documentation in half while fully complying with Joint Commission...
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: TPO disclosures to a business associate
- Q/A: Coding infusions to correct low potassium levels
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- State medical board will hear unprofessional charges against OB-GYN
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- Major mobile operators to support free text alerts
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding infusions to correct low potassium levels
- Know criteria for coverage when podiatrists use Dermagraft® tissue substitute
- Note: Clarification of reference (non-patient) laboratory testing
- HIPAA Q&A: TPO disclosures to a business associate
- Get the facts on coding for non-biodegradeable drug delivery implants
- Facility E/M Levels, 2009 OPPS
- Do not separately report defibrillation
- Defining 'integral' for self-administered drugs is challenging
- Consider the big picture before querying physicians
- Searched